XOMA (US) LLC
2910 Seventh Street
Berkeley
California
94710
United States
Tel: 510-204-7200 or 800-BIO-XOMA<br>
Fax: 510-644-0539
Website: http://www.xoma.com/
324 articles about XOMA (US) LLC
-
Results From Two Phase 2 Studies in XOMA (US) LLC's Gevokizumab Proof-of-Concept Program Are Very Encouraging and Compelling
10/31/2013
-
XOMA (US) LLC to Present at the Morgan Stanley Healthcare Conference
9/6/2013
-
XOMA (US) LLC Announces Pricing of $27.5 Million Offering of Common Stock
8/20/2013
-
XOMA (US) LLC to Present at Two Upcoming Investor Conferences
8/9/2013
-
XOMA (US) LLC Highlights Recent Achievements and Reports Financial Results for Second Quarter 2013
8/8/2013
-
XOMA (US) LLC to Announce Second Quarter 2013 Financial Results and Host Webcast on August 7
7/25/2013
-
XOMA (US) LLC Completes Enrollment in Phase 2 Proof-of-Concept Gevokizumab Trial in Patients With Erosive Osteoarthritis of the Hand
7/22/2013
-
XOMA (US) LLC Hands Off Hypertension Drug Franchise to Startup Launched by Former Employees
7/8/2013
-
XOMA (US) LLC to Present at the JMP Securities Healthcare Conference
7/3/2013
-
XOMA (US) LLC's Development Partner Servier Launches Proof-of-Concept Clinical Program for Gevokizumab
6/25/2013
-
XOMA (US) LLC Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma Gangrenosum
6/13/2013
-
XOMA (US) LLC Highlights Recent Achievements and Reports Financial Results for First Quarter 2013
5/9/2013
-
XOMA (US) LLC to Present at Credit Suisse First Boston 2013 Antibody Day
5/7/2013
-
XOMA (US) LLC Announces Encouraging Interim Results From Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris
1/7/2013
-
XOMA (US) LLC Selects Non-Infectious Anterior Scleritis as Next Indication in Gevokizumab Proof-of-Concept Program
1/2/2013
-
XOMA (US) LLC Appoints Joseph M. Limber to Its Board of Directors
12/13/2012
-
XOMA (US) LLC to Present at Credit Suisse Healthcare Conference
11/9/2012
-
XOMA (US) LLC Reports Financial Results for Third Quarter 2012 and Highlights Recent Achievements
11/8/2012
-
XOMA (US) LLC to Announce Third Quarter 2012 Financial Results and Host Webcast on November 7
11/1/2012
-
XOMA (US) LLC Announces Pricing of $40.0 Million Public Offering of Common Stock
10/24/2012